2016
DOI: 10.1016/j.joca.2016.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Guiding synovial inflammation by macrophage phenotype modulation: an in vitro study towards a therapy for osteoarthritis

Abstract: These data indicate that macrophage phenotype modulation can be used to guide joint inflammation and thereby contribute to the development of new therapies to delay the progression of OA. The varying effects of the compounds on synovium of different degrees of inflammation, indicate that the modulatory capacity of the compounds depends on OA stage and underlines the importance of identifying this stadium for adequate treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
52
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(58 citation statements)
references
References 49 publications
5
52
1
Order By: Relevance
“…Macrophages are accumulated and polarised (M1 or M2) in the synovium and articular cavity during OA development, suggesting a correlation between macrophages and OA 25. A recent in vitro study by Utomo et al revealed that M1 but not M2 macrophages exert prominent effects on inflammation and degeneration of cultured cartilage explants 39. Furthermore, systemic depletion of macrophages reduces osteophyte formation in a collagen-induced arthritis model 40.…”
Section: Discussionmentioning
confidence: 99%
“…Macrophages are accumulated and polarised (M1 or M2) in the synovium and articular cavity during OA development, suggesting a correlation between macrophages and OA 25. A recent in vitro study by Utomo et al revealed that M1 but not M2 macrophages exert prominent effects on inflammation and degeneration of cultured cartilage explants 39. Furthermore, systemic depletion of macrophages reduces osteophyte formation in a collagen-induced arthritis model 40.…”
Section: Discussionmentioning
confidence: 99%
“…In OA severity and progression, it has been demonstrated that inflammation is mainly mediated by soluble factors and infiltrating immune cells. Macrophages are key effector cells in synovial tissue 11 significantly increasing in number and guiding synovial inflammation 12 . The presence of both M1 and M2 macrophages in human OA synovial tissue has been described in a few studies 21,22 where the focus has mainly been on the levels of their expression rather than on their function.…”
Section: Discussionmentioning
confidence: 99%
“…Macrophages represent the cell population mainly located in the synovial lining layer that significantly increase in number with the increase of synovial inflammation grading from low to high. We have shown that macrophages are key effector cells in the synovial tissue 11 and it has been shown that these cells guide synovial inflammation 12 . Depletion of synovial macrophages in an OA mouse model reduces osteophyte formation and cartilage degeneration, typical features of OA progression 13 .…”
Section: Introductionmentioning
confidence: 99%
“…It has been reported that dexamethasone does not account for increases in chondrogenic activity but may increase osteogenic activity (33). In addition, dexamethasone is a pharmacological agent that has been used to suppress inflammation (34). Certain previous studies added dexamethasone to the medium when preparing cultures; however, it is important to ensure that dexamethasone is not added to cultural environments, as it may suppress chondrocyte proliferation (35,36).…”
Section: Discussionmentioning
confidence: 99%